Staar Surgical CoSTAA -0.72%83 Cyclically Adjusted PB Ratio is 5.21 as of Jul. 11, 2026, which is 73% below its 10-year median of 19.65. GuruFocus rates STAA with a GF Score™ of 83/100 and a GF Value™ of $31.96 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 524 Medical Devices & Instruments companies, Staar Surgical Co ranks worse than 82.06% on this metric.
The historical rank and industry rank for Staar Surgical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:
STAA'
s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.16 Med: 19.65 Max: 85.36
Current: 5.21
During the past years, Staar Surgical Co's highest Cyclically Adjusted PB Ratio was 85.36. The lowest was 3.16. And the median was 19.65.
STAA's Cyclically Adjusted PB Ratio is ranked worse than 82.06% of 524
companies
in the Medical Devices & Instruments industry
Industry Median: 1.79
vs STAA: 5.21
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Staar Surgical Co's adjusted book value per share data for the three months ended in Mar. 2026 was $7.078. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $5.33 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Staar Surgical Co (NAS:STAA) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Staar Surgical Co Cyclically Adjusted PB Ratio Related Terms
Staar Surgical Co Cyclically Adjusted PB Ratio Historical Data
* Premium members only.
The historical data trend for Staar Surgical Co's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co Cyclically Adjusted PB Ratio Chart
STAA vs BLFS, ATRC, KMTS: Cyclically Adjusted PB Ratio Comparison
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's Cyclically Adjusted PB Ratio falls into.
Staar Surgical Co Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Staar Surgical Co's Cyclically Adjusted PB Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 5.21 mean?
Staar Surgical Co (STAA) has a Cyclically Adjusted PB Ratio of 5.21 as of Jul. 11, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Staar Surgical Co and its competitors. This is 73% below median its historical median of 19.65. Over the past decade, Staar Surgical Co's Cyclically Adjusted PB Ratio has ranged from 3.16 to 85.36. According to the industry distribution chart, Staar Surgical Co ranks #430 out of 524 companies in the Medical Devices & Instruments industry, placing it in the top 82.1%.
Is Staar Surgical Co's Cyclically Adjusted PB Ratio too high?
Staar Surgical Co's current Cyclically Adjusted PB Ratio of 5.21 is 73% below median its 10-year median of 19.65. Over the past 10 years, this metric has ranged from a low of 3.16 to a high of 85.36. The Medical Devices & Instruments industry median Cyclically Adjusted PB Ratio is 1.79. Staar Surgical Co's value of 5.21 is 191.1% above this industry median. Based on the distribution chart, Staar Surgical Co ranks #430 out of 524 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Staar Surgical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's Cyclically Adjusted PB Ratio compare to BLFS and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #430 out of 524 companies for Cyclically Adjusted PB Ratio. This places Staar Surgical Co in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.79. Staar Surgical Co's value of 5.21 is 191.1% above this benchmark. Historically, Staar Surgical Co's own Cyclically Adjusted PB Ratio has ranged from 3.16 to 85.36 over the past decade. While the company's 10-year median is 19.65 vs. the industry median of 1.79, Staar Surgical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PB Ratio among Medical Devices & Instruments companies is 1.79, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Staar Surgical Co's current Cyclically Adjusted PB Ratio of 5.21 is 191.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Staar Surgical Co and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PB Ratio is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current Cyclically Adjusted PB Ratio is 5.21, which is 73% below median its own 10-year median of 19.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.96, compared to a current price of $27.75 — trading 13.2% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 5.21, which is 73% below median its 10-year median of 19.65 and 191.1% above the Medical Devices & Instruments industry median of 1.79. Staar Surgical Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current Cyclically Adjusted PB Ratio is 5.21 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $27.75 is trading 13.2% below its estimated GF Value™ of $31.96.
GuruFocus considers Staar Surgical Co to be Modestly Undervalued.
Key valuation signals for STAA:
Cyclically Adjusted PB Ratio: 5.21 (73% below median its 10-year median of 19.65)
GF Value™: $31.96 vs. price of $27.75 (13.2% below fair value)
Industry Position: 191.1% above the Medical Devices & Instruments median (#430 of 524)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
83GF Score
Get the complete analysis for STAA
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 
